Larry Pietrelli

704 total citations
7 papers, 477 citations indexed

About

Larry Pietrelli is a scholar working on Infectious Diseases, Oncology and Pharmacology. According to data from OpenAlex, Larry Pietrelli has authored 7 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Larry Pietrelli's work include Antifungal resistance and susceptibility (6 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Fungal Infections and Studies (2 papers). Larry Pietrelli is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Fungal Infections and Studies (2 papers). Larry Pietrelli collaborates with scholars based in United States, Canada and Argentina. Larry Pietrelli's co-authors include Marc Gurwith, Raleigh A. Bowden, Gary A. Noskin, John R. Wingard, Pranatharthi Chandrasekar, Sharon Safrin, Michél Laverdière, Xin Li, Mary H. White and Jo‐Anne van Burik and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Bone Marrow Transplantation.

In The Last Decade

Larry Pietrelli

7 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry Pietrelli United States 7 437 371 82 60 38 7 477
Myrna Candelario United States 6 535 1.2× 416 1.1× 76 0.9× 40 0.7× 109 2.9× 7 581
Rocus R. Klont Netherlands 7 399 0.9× 321 0.9× 48 0.6× 27 0.5× 18 0.5× 9 450
Carmen Pazos Spain 4 427 1.0× 386 1.0× 36 0.4× 33 0.6× 16 0.4× 6 455
E. Kukučková Slovakia 12 197 0.5× 165 0.4× 19 0.2× 87 1.4× 40 1.1× 21 312
Maria N. Chitasombat Thailand 10 199 0.5× 221 0.6× 88 1.1× 19 0.3× 18 0.5× 16 337
Dorien Ruegebrink Netherlands 6 272 0.6× 235 0.6× 26 0.3× 24 0.4× 16 0.4× 7 309
Wirawan Jeong Australia 6 675 1.5× 414 1.1× 49 0.6× 27 0.5× 79 2.1× 8 740
Johanna E. Hughes United States 6 290 0.7× 229 0.6× 63 0.8× 12 0.2× 36 0.9× 6 337
Peter Rath Germany 7 213 0.5× 173 0.5× 21 0.3× 41 0.7× 15 0.4× 13 309
M. Aupée France 2 255 0.6× 224 0.6× 43 0.5× 26 0.4× 12 0.3× 4 295

Countries citing papers authored by Larry Pietrelli

Since Specialization
Citations

This map shows the geographic impact of Larry Pietrelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Pietrelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Pietrelli more than expected).

Fields of papers citing papers by Larry Pietrelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Pietrelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Pietrelli. The network helps show where Larry Pietrelli may publish in the future.

Co-authorship network of co-authors of Larry Pietrelli

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Pietrelli. A scholar is included among the top collaborators of Larry Pietrelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Pietrelli. Larry Pietrelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bowden, Raleigh A., Pranatharthi Chandrasekar, Mary H. White, et al.. (2002). A Double‐Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients. Clinical Infectious Diseases. 35(4). 359–366. 225 indexed citations
2.
Herbrecht, Raoul, V. Letscher‐Bru, Raleigh A. Bowden, et al.. (2001). Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion. European Journal of Clinical Microbiology & Infectious Diseases. 20(7). 460–466. 101 indexed citations
3.
Sandler, Eric, Mahmoud M. Mustafa, Isabelle Tkaczewski, et al.. (2000). Use of Amphotericin B Colloidal Dispersion in Children. ˜The œAmerican journal of pediatric hematology/oncology. 22(3). 242–246. 47 indexed citations
4.
Gurwith, Marc, Richard D. Mamelok, Larry Pietrelli, & Charles Du Mond. (1999). Renal Sparing by Amphotericin B Colloidal Dispersion: Clinical Experience in 572 Patients. Chemotherapy. 45(Suppl. 1). 39–47. 10 indexed citations
5.
Noskin, Gary A., Larry Pietrelli, Marc Gurwith, & Raleigh A. Bowden. (1999). Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients. Bone Marrow Transplantation. 23(7). 697–703. 23 indexed citations
6.
Noskin, Gary A., et al.. (1998). Amphotericin B Colloidal Dispersion for Treatment of Candidemia in Immunocompromised Patients. Clinical Infectious Diseases. 26(2). 461–467. 28 indexed citations
7.
Anaissie, Elias, Gloria Mattiuzzi, Carole B. Miller, et al.. (1998). Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion. Antimicrobial Agents and Chemotherapy. 42(3). 606–611. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026